Atlas Trials

Locally Advanced or Metastatic Breast Cancer

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Locally Advanced or Metastatic Breast Cancer

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of Giredestrant in Combination With Phesgo (Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf) Versus Phesgo in Participants With Locally Advanced or Metastatic Breast Cancer (heredERA Breast Cancer) (NCT05296798)Hoffmann-La Roche2022-07-18
Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer (NCT05430399)Sun Yat-sen University2022-06-21
Weekly Utidelone in HER2-negative Inoperable Locally Advanced or Metastatic Breast Cancer (NCT05403333)Fudan University2022-06-10
To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer (NCT05212701)Dompé Farmaceutici S.p.A2022-04-19
Utidelone Plus Capecitabine Versus Taxane Plus Capecitabine in HER2-negative Locally Advanced or Metastatic Breast Cancer (NCT05172518)Sun Yat-sen University2022-03-01
GB491 Combined With Fulvestrant for HR+ HER2- Locally Advanced or Metastatic Breast Cancer (NCT05054751)Genor Biopharma Co., Ltd.2021-09-10
Evaluation of Lasofoxifene Versus Fulvestrant in Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation (NCT03781063)Sermonix Pharmaceuticals Inc.2019-09-20
A Study to Investigate the Efficacy and Safety of Eribulin in Korean Breast Cancer Participants (NCT03437083)Eisai Korea Inc.2018-01-25
Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (NCT03027245)Eisai GmbH2016-10-13
Phase I Study of Ixabepilone Plus Lapatinib With or Without Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer (NCT00634088)R-Pharm2008-06-01

Track Locally Advanced or Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.